Evaluation of thyroid-stimulating hormone-increased, hypertriglyceridemia and proteinuria as markers of anlotinib efficacy in advanced soft tissue sarcoma.

Yihebali Chi,Yang Yao,Zhiwei Fang,Shusen Wang,Gang Huang,Qiqing Cai,G Shang,Guowen Wang,Guofan Qu,Qiong Wu,Yu Jiang,Jianmin Song,Jing Chen,Xia Zhu,Zhengdong Cai,Chunmei Bai,Yongkui Lu,Zhihua Yu,Jingnan Shen,Jianqiang Cai

Evaluation of thyroid-stimulating hormone-increased, hypertriglyceridemia and proteinuria as markers of anlotinib efficacy in advanced soft tissue sarcoma.

2020

e23548Background: ALTER0203 was a randomized phase IIB trial (NCT02449343) that demonstrated single-agent activity of anlotinib in advanced STS (aSTS). The primary endpoint progression-free surviva...

Keywords:

Thyroid-stimulating hormone
Proteinuria
Soft tissue sarcoma
Pathology
Hypertriglyceridemia
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations